Kura Oncology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -48.5% | -42.9% | -39.5% |
| FY2017 | -44.4% | -41.5% | -37.0% |
| FY2018 | -37.5% | -35.9% | -33.1% |
| FY2019 | -28.9% | -27.9% | -26.1% |
| FY2020 | -14.7% | -14.6% | -13.8% |
| FY2021 | -25.8% | -25.8% | -24.4% |
| FY2022 | -32.3% | -31.6% | -29.8% |
| FY2023 | -38.4% | -37.5% | -34.0% |
| FY2024 | -42.1% | -41.4% | -22.9% |
| FY2025 | -160.0% | -151.6% | -37.7% |